Home / Business and Economy / Tata Consumer Eyes Danone's India Nutrition Assets
Tata Consumer Eyes Danone's India Nutrition Assets
8 Dec, 2025
Summary
- Tata Consumer Products is in advanced talks to buy Danone's India nutraceuticals and specialized nutrition portfolio.
- An acquisition would help Tata Consumer expand its presence in the rapidly growing wellness and nutrition market.
- Danone's India nutrition business includes prominent brands like Farex, Dexolac, and Protinex.
Tata Consumer Products is reportedly in advanced negotiations to acquire Danone SA's specialized nutrition and nutraceuticals business in India. This strategic move aligns with TCPL's ambition to significantly expand its footprint in the burgeoning wellness and nutrition sector. The potential acquisition would mark TCPL's entry into the value-added nutrition segment, pitting it against formidable competitors like Nestlé and Abbott.
Recent months have seen intensified discussions, with both parties nearing an agreement on valuation. This proposed deal would integrate Danone's established Indian nutrition portfolio, which includes brands such as Farex, Dexolac, and Protinex, into Tata Consumer's growing wellness ecosystem. TCPL has actively pursued acquisitions, including Soulfull, Capital Foods, and Organic India, to diversify beyond its core staples and tea offerings.
Danone's India nutrition division, acquired from Wockhardt for Rs 1,576 crore, is a significant player in baby nutrition and adult protein supplements. These segments are experiencing robust growth, driven by increasing consumer focus on preventive health and immunity. India's young demographic and aging population present substantial market opportunities for specialized nutrition products.
